Literature DB >> 9449382

Endothelin-converting enzyme: ultrastructural localization and its recycling from the cell surface.

K Barnes1, C Brown, A J Turner.   

Abstract

The potent vasoconstrictor endothelin-1 (ET-1) is secreted constitutively by endothelial cells and has been implicated in the pathophysiology of several cardiovascular diseases. It is generated from its inactive intermediate, big ET-1, through the action of endothelin-converting enzyme (ECE). Using several complementary techniques, we have demonstrated that ECE is present at the cell surface and on intracellular vesicles and that it recycles from the cell surface in endothelial cells. This is the first ultrastructural localization of ECE in lung and the first time big ET-1 and ECE have been colocalized by immunogold in a vesicular population, 50 to 100 nm in diameter. In addition, by double immunogold staining of ultrathin cryosections, we have localized ECE together with angiotensin-converting enzyme on the luminal membrane of endothelial cells. With cell surface biotinylation of a transformed rat endothelial cell line and of human umbilical vein endothelial cells, we have confirmed the presence of ECE on the plasma membrane. After treatment of endothelial cells with chloroquine, ECE and trans-Golgi network 38 protein were shown by immunofluorescence staining to localize to the same intracellular compartment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449382     DOI: 10.1161/01.hyp.31.1.3

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries.

Authors:  Aditya Goel; Baogen Su; Sheila Flavahan; Charles J Lowenstein; Dan E Berkowitz; Nicholas A Flavahan
Journal:  Circ Res       Date:  2010-06-03       Impact factor: 17.367

Review 4.  The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

Authors:  N S Kirkby; P W F Hadoke; A J Bagnall; D J Webb
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 5.  Eyeing endothelins: a cellular perspective.

Authors:  Ganesh Prasanna; Santosh Narayan; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

6.  Cyclic expression of endothelin-converting enzyme-1 mediates the functional regulation of seminiferous tubule contraction.

Authors:  A Tripiciano; C Peluso; A R Morena; F Palombi; M Stefanini; E Ziparo; M Yanagisawa; A Filippini
Journal:  J Cell Biol       Date:  1999-05-31       Impact factor: 10.539

Review 7.  Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzyme.

Authors:  Sanjaya Kuruppu; Niwanthi W Rajapakse; Helena C Parkington; Ian Smith
Journal:  Pharmacol Res Perspect       Date:  2017-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.